Regulatory Approval & Compliance Challenges: The company faces ongoing regulatory hurdles for its diagnostic products and nutraceuticals, including the need for FDA clearances, adherence to CLIA standards, and compliance with various health and safety regulations, any of which could delay or prevent product launch or force costly modifications.

Intense Market Competition: Prophase Labs operates in highly competitive markets for both molecular diagnostics and nutraceuticals, facing numerous established companies with greater resources, extensive distribution networks, and brand recognition, which could limit market share and pricing power.

New Product Adoption & Commercialization Risk: The success of Prophase Labs significantly depends on the market acceptance and commercialization of its new diagnostic tests and nutraceutical products, which may not gain sufficient traction among healthcare providers or consumers despite development efforts.